SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-17-003641
Filing Date
2017-06-14
Accepted
2017-06-14 16:31:32
Documents
2
Period of Report
2017-06-01

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formthree.html 3  
1 OWNERSHIP DOCUMENT formthree.xml 3 2850
2 EXHIBIT 24 exh_24.htm EX-24 7393
  Complete submission text file 0001171843-17-003641.txt   11603
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Issuer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SUPERNUS PHARMACEUTICALS, INC. 1550 EAST GUDE DRIVE ROCKVILLE MD 20850
Business Address
Bryan Jones W. (Reporting) CIK: 0001540660 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33609 | Film No.: 17911488